Aug 07, 2025 • Motley Fool
SOMEWHAT-BULLISH
Procept ( PRCT ) Q2 Revenue Jumps 48%
Procept BioRobotics ( NASDAQ:PRCT ) , a medical technology company specializing in robotic surgical systems for benign prostatic hyperplasia ( BPH ) treatment, posted second-quarter 2025 results on August 6, 2025. The company reported GAAP revenue of $79.2 million, surpassing analyst estimates.
Aug 06, 2025 • Zacks Commentary
NEUTRAL
PROCEPT BioRobotics Corporation ( PRCT ) Reports Q2 Loss, Lags Revenue Estimates
PROCEPT BioRobotics (PRCT) delivered earnings and revenue surprises of +14.63% and -0.02%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Aug 06, 2025 • Motley Fool
SOMEWHAT-BULLISH
PROCEPT BioRobotics ( PRCT ) Earnings Transcript
Image source: The Motley Fool.Aug. 6, 2025, 8:30 p.m. ETChief Executive Officer - Reza ZadnoContinue reading ...
Aug 05, 2025 • Zacks Commentary
NEUTRAL
AxoGen ( AXGN ) Beats Q2 Earnings and Revenue Estimates
AxoGen (AXGN) delivered earnings and revenue surprises of +100.00% and +7.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Aug 04, 2025 • Zacks Commentary
NEUTRAL
Si-Bone ( SIBN ) Reports Q2 Loss, Beats Revenue Estimates
Si-Bone (SIBN) delivered earnings and revenue surprises of +26.32% and +0.80%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Jul 31, 2025 • Zacks Commentary
NEUTRAL
Envoy Medical, Inc. ( COCH ) Reports Q2 Loss, Tops Revenue Estimates
Envoy Medical, Inc. (COCH) delivered earnings and revenue surprises of -10.34% and +39.29%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?